Multi-analyte profiling reveals matrix metalloproteinase-9 and monocyte chemotactic protein-1 as plasma biomarkers of cardiac aging

Ying Ann Chiao, Qiuxia Dai, Jianhua Zhang, Jing Lin, Elizabeth F. Lopez, Seema S. Ahuja, Youn Min Chou, Merry L. Lindsey, Yu Fang Jin

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Background - We have previously shown that cardiac sarcopenia occurs with age in C57/BL6J mice. However, underlying mechanisms and plasma biomarkers of cardiac aging have not been identified. Accordingly, the objective of this study was to identify and evaluate plasma biomarkers that reflect cardiac aging phenotypes. Methods and Results - Plasma from adult (7.5±0.5 months old, n=27) and senescent (31.7±0.5 months old, n=25) C57/BL6J mice was collected, and levels of 69 markers were measured by multi-analyte profiling. Of these, 26 analytes were significantly increased and 3 were significantly decreased in the senescent group compared with the adult group. The majority of analytes that increased in the senescent group were inflammatory markers associated with macrophage functions, including matrix metalloproteinase-9 (MMP-9) and monocyte chemotactic protein-1 (MCP-1/CCL-2). Immunoblotting (n=12/group) showed higher MMP-9 and MCP-1 levels in the left ventricle (LV) of senescent mice (P<0.05), and their expression levels in the LV correlated with plasma levels (ρ=0.50 for MMP-9 and ρ=0.62 for MCP1, P<0.05). Further, increased plasma MCP-1 and MMP-9 levels correlated with the increase in end-diastolic dimensions that occurs with senescence. Immunohistochemistry (n=3/group) for Mac-3, a macrophage marker, showed increased macrophage densities in the senescent LV, and dual-labeling immunohistochemistry of Mac-3 and MMP-9 revealed robust colocalization of MMP-9 to the macrophages in the senescent LV sections, indicating that the macrophage is a major contributor of MMP-9 in the senescent LV. Conclusions - Our results suggest that MCP-1 and MMP-9 are potential plasma markers for cardiac aging and that augmented MCP-1 and MMP-9 levels and macrophage content in the LV could provide an underlying inflammatory mechanism of cardiac aging.

Original languageEnglish (US)
Pages (from-to)455-462
Number of pages8
JournalCirculation: Cardiovascular Genetics
Volume4
Issue number4
DOIs
StatePublished - Aug 1 2011

Fingerprint

Chemokine CCL2
Matrix Metalloproteinase 9
Biomarkers
Heart Ventricles
Macrophages
Immunohistochemistry
Sarcopenia
Immunoblotting
Phenotype

Keywords

  • Aging
  • Biomarker
  • Macrophage
  • Metalloproteinase
  • Myocardium

ASJC Scopus subject areas

  • Genetics
  • Cardiology and Cardiovascular Medicine
  • Genetics(clinical)

Cite this

Multi-analyte profiling reveals matrix metalloproteinase-9 and monocyte chemotactic protein-1 as plasma biomarkers of cardiac aging. / Chiao, Ying Ann; Dai, Qiuxia; Zhang, Jianhua; Lin, Jing; Lopez, Elizabeth F.; Ahuja, Seema S.; Chou, Youn Min; Lindsey, Merry L.; Jin, Yu Fang.

In: Circulation: Cardiovascular Genetics, Vol. 4, No. 4, 01.08.2011, p. 455-462.

Research output: Contribution to journalArticle

Chiao, Ying Ann ; Dai, Qiuxia ; Zhang, Jianhua ; Lin, Jing ; Lopez, Elizabeth F. ; Ahuja, Seema S. ; Chou, Youn Min ; Lindsey, Merry L. ; Jin, Yu Fang. / Multi-analyte profiling reveals matrix metalloproteinase-9 and monocyte chemotactic protein-1 as plasma biomarkers of cardiac aging. In: Circulation: Cardiovascular Genetics. 2011 ; Vol. 4, No. 4. pp. 455-462.
@article{29bd643018dd41009c2ab604801f827a,
title = "Multi-analyte profiling reveals matrix metalloproteinase-9 and monocyte chemotactic protein-1 as plasma biomarkers of cardiac aging",
abstract = "Background - We have previously shown that cardiac sarcopenia occurs with age in C57/BL6J mice. However, underlying mechanisms and plasma biomarkers of cardiac aging have not been identified. Accordingly, the objective of this study was to identify and evaluate plasma biomarkers that reflect cardiac aging phenotypes. Methods and Results - Plasma from adult (7.5±0.5 months old, n=27) and senescent (31.7±0.5 months old, n=25) C57/BL6J mice was collected, and levels of 69 markers were measured by multi-analyte profiling. Of these, 26 analytes were significantly increased and 3 were significantly decreased in the senescent group compared with the adult group. The majority of analytes that increased in the senescent group were inflammatory markers associated with macrophage functions, including matrix metalloproteinase-9 (MMP-9) and monocyte chemotactic protein-1 (MCP-1/CCL-2). Immunoblotting (n=12/group) showed higher MMP-9 and MCP-1 levels in the left ventricle (LV) of senescent mice (P<0.05), and their expression levels in the LV correlated with plasma levels (ρ=0.50 for MMP-9 and ρ=0.62 for MCP1, P<0.05). Further, increased plasma MCP-1 and MMP-9 levels correlated with the increase in end-diastolic dimensions that occurs with senescence. Immunohistochemistry (n=3/group) for Mac-3, a macrophage marker, showed increased macrophage densities in the senescent LV, and dual-labeling immunohistochemistry of Mac-3 and MMP-9 revealed robust colocalization of MMP-9 to the macrophages in the senescent LV sections, indicating that the macrophage is a major contributor of MMP-9 in the senescent LV. Conclusions - Our results suggest that MCP-1 and MMP-9 are potential plasma markers for cardiac aging and that augmented MCP-1 and MMP-9 levels and macrophage content in the LV could provide an underlying inflammatory mechanism of cardiac aging.",
keywords = "Aging, Biomarker, Macrophage, Metalloproteinase, Myocardium",
author = "Chiao, {Ying Ann} and Qiuxia Dai and Jianhua Zhang and Jing Lin and Lopez, {Elizabeth F.} and Ahuja, {Seema S.} and Chou, {Youn Min} and Lindsey, {Merry L.} and Jin, {Yu Fang}",
year = "2011",
month = "8",
day = "1",
doi = "10.1161/CIRCGENETICS.111.959981",
language = "English (US)",
volume = "4",
pages = "455--462",
journal = "Circulation. Genomic and precision medicine",
issn = "1942-325X",
publisher = "Lippincott Williams and Wilkins Ltd.",
number = "4",

}

TY - JOUR

T1 - Multi-analyte profiling reveals matrix metalloproteinase-9 and monocyte chemotactic protein-1 as plasma biomarkers of cardiac aging

AU - Chiao, Ying Ann

AU - Dai, Qiuxia

AU - Zhang, Jianhua

AU - Lin, Jing

AU - Lopez, Elizabeth F.

AU - Ahuja, Seema S.

AU - Chou, Youn Min

AU - Lindsey, Merry L.

AU - Jin, Yu Fang

PY - 2011/8/1

Y1 - 2011/8/1

N2 - Background - We have previously shown that cardiac sarcopenia occurs with age in C57/BL6J mice. However, underlying mechanisms and plasma biomarkers of cardiac aging have not been identified. Accordingly, the objective of this study was to identify and evaluate plasma biomarkers that reflect cardiac aging phenotypes. Methods and Results - Plasma from adult (7.5±0.5 months old, n=27) and senescent (31.7±0.5 months old, n=25) C57/BL6J mice was collected, and levels of 69 markers were measured by multi-analyte profiling. Of these, 26 analytes were significantly increased and 3 were significantly decreased in the senescent group compared with the adult group. The majority of analytes that increased in the senescent group were inflammatory markers associated with macrophage functions, including matrix metalloproteinase-9 (MMP-9) and monocyte chemotactic protein-1 (MCP-1/CCL-2). Immunoblotting (n=12/group) showed higher MMP-9 and MCP-1 levels in the left ventricle (LV) of senescent mice (P<0.05), and their expression levels in the LV correlated with plasma levels (ρ=0.50 for MMP-9 and ρ=0.62 for MCP1, P<0.05). Further, increased plasma MCP-1 and MMP-9 levels correlated with the increase in end-diastolic dimensions that occurs with senescence. Immunohistochemistry (n=3/group) for Mac-3, a macrophage marker, showed increased macrophage densities in the senescent LV, and dual-labeling immunohistochemistry of Mac-3 and MMP-9 revealed robust colocalization of MMP-9 to the macrophages in the senescent LV sections, indicating that the macrophage is a major contributor of MMP-9 in the senescent LV. Conclusions - Our results suggest that MCP-1 and MMP-9 are potential plasma markers for cardiac aging and that augmented MCP-1 and MMP-9 levels and macrophage content in the LV could provide an underlying inflammatory mechanism of cardiac aging.

AB - Background - We have previously shown that cardiac sarcopenia occurs with age in C57/BL6J mice. However, underlying mechanisms and plasma biomarkers of cardiac aging have not been identified. Accordingly, the objective of this study was to identify and evaluate plasma biomarkers that reflect cardiac aging phenotypes. Methods and Results - Plasma from adult (7.5±0.5 months old, n=27) and senescent (31.7±0.5 months old, n=25) C57/BL6J mice was collected, and levels of 69 markers were measured by multi-analyte profiling. Of these, 26 analytes were significantly increased and 3 were significantly decreased in the senescent group compared with the adult group. The majority of analytes that increased in the senescent group were inflammatory markers associated with macrophage functions, including matrix metalloproteinase-9 (MMP-9) and monocyte chemotactic protein-1 (MCP-1/CCL-2). Immunoblotting (n=12/group) showed higher MMP-9 and MCP-1 levels in the left ventricle (LV) of senescent mice (P<0.05), and their expression levels in the LV correlated with plasma levels (ρ=0.50 for MMP-9 and ρ=0.62 for MCP1, P<0.05). Further, increased plasma MCP-1 and MMP-9 levels correlated with the increase in end-diastolic dimensions that occurs with senescence. Immunohistochemistry (n=3/group) for Mac-3, a macrophage marker, showed increased macrophage densities in the senescent LV, and dual-labeling immunohistochemistry of Mac-3 and MMP-9 revealed robust colocalization of MMP-9 to the macrophages in the senescent LV sections, indicating that the macrophage is a major contributor of MMP-9 in the senescent LV. Conclusions - Our results suggest that MCP-1 and MMP-9 are potential plasma markers for cardiac aging and that augmented MCP-1 and MMP-9 levels and macrophage content in the LV could provide an underlying inflammatory mechanism of cardiac aging.

KW - Aging

KW - Biomarker

KW - Macrophage

KW - Metalloproteinase

KW - Myocardium

UR - http://www.scopus.com/inward/record.url?scp=80052727564&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052727564&partnerID=8YFLogxK

U2 - 10.1161/CIRCGENETICS.111.959981

DO - 10.1161/CIRCGENETICS.111.959981

M3 - Article

C2 - 21685172

AN - SCOPUS:80052727564

VL - 4

SP - 455

EP - 462

JO - Circulation. Genomic and precision medicine

JF - Circulation. Genomic and precision medicine

SN - 1942-325X

IS - 4

ER -